Company Overview of H-Phar S.A.
H-Phar S.A. operates as a pharmaceutical research company that develops candidate drugs based on its own worldwide patented technology. It engages in preclinical research for the development of anti-viral applications in the domain of hemorrhagic fever and oncoviruses, and immune-modulator drugs inhibiting graft rejection; clinical development of anti-HIV drugs; and synthesis and evaluation of biological activities of low molecular weight azo-compounds. H-Phar S.A. was founded in 2002 and is based in Gosselies, Belgium.
Rue Clément Ader 12
Founded in 2002
32 7 135 76 57
32 7 135 76 57
Key Executives for H-Phar S.A.
Similar Private Companies By Industry
|Apotheek Delestre NV||Europe|
|Apotheek Moons NV||Europe|
|Apotheek Philips NV||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact H-Phar S.A., please visit www.h-phar.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.